Your browser doesn't support javascript.
loading
Clinical features and outcomes of fusion gene defined adult Ph-negative B-cell precursor acute lymphoblastic leukemia patients: A single institutional report.
Sun, Kai; Wang, Jun; Chen, Wen-Min; Xu, Nan; Long, Ling-Yu; Wang, Xu; Jiang, Hao; Jiang, Qian; Huang, Xiao-Jun; Qin, Ya-Zhen.
Affiliation
  • Sun K; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Wang J; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Chen WM; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Xu N; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Long LY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Wang X; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Jiang H; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Qin YZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Biomol Biomed ; 23(2): 298-309, 2023 Mar 16.
Article de En | MEDLINE | ID: mdl-36124444

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines de fusion oncogènes / Leucémie-lymphome lymphoblastique à précurseurs B et T Type d'étude: Prognostic_studies Limites: Adult / Humans Langue: En Journal: Biomol Biomed Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Bosnie-Herzégovine

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines de fusion oncogènes / Leucémie-lymphome lymphoblastique à précurseurs B et T Type d'étude: Prognostic_studies Limites: Adult / Humans Langue: En Journal: Biomol Biomed Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Bosnie-Herzégovine